A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus*

Tat is an 86-amino acid protein involved in the replication of human immunodeficiency virus type 1 (HIV-1). Several studies have shown that exogenous Tat protein was able to translocate through the plasma membrane and to reach the nucleus to transactivate the viral genome. A region of the Tat protein centered on a cluster of basic amino acids has been assigned to this translocation activity. Recent data have demonstrated that chemical coupling of a Tat-derived peptide (extending from residues 37 to 72) to several proteins allowed their functional internalization into several cell lines or tissues. A part of this same domain can be folded in an α-helix structure with amphipathic characteristics. Such helical structures have been considered as key determinants for the uptake of several enveloped viruses by fusion or endocytosis. In the present study, we have delineated the main determinants required for Tat translocation within this sequence by synthesizing several peptides covering the Tat domain from residues 37 to 60. Unexpectedly, the domain extending from amino acid 37 to 47, which corresponds to the α-helix structure, is not required for cellular uptake and for nuclear translocation. Peptide internalization was assessed by direct labeling with fluorescein or by indirect immunofluorescence using a monoclonal antibody directed against the Tat basic cluster. Both approaches established that all peptides containing the basic domain are taken up by cells within less than 5 min at concentrations as low as 100 nm. In contrast, a peptide with a full α-helix but with a truncated basic amino acid cluster is not taken up by cells. The internalization process does not involve an endocytic pathway, as no inhibition of the uptake was observed at 4 °C. Similar observations have been reported for a basic amino acid-rich peptide derived from the Antennapedia homeodomain (1). Short peptides allowing efficient translocation through the plasma membrane could be useful vectors for the intracellular delivery of various non-permeant drugs including antisense oligonucleotides and peptides of pharmacological interest.

[1]  A. Prochiantz,et al.  Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.

[2]  B. Lebleu Delivering information-rich drugs--prospects and challenges. , 1996, Trends in biotechnology.

[3]  K. Breslauer,et al.  Hybridization properties of oligodeoxynucleotide pairs bridged by polyarginine peptides. , 1996, Nucleic acids research.

[4]  R. Ruigrok,et al.  Low-pH induced conformational changes in viral fusion proteins: implications for the fusion mechanism. , 1995, The Journal of general virology.

[5]  P. Oh,et al.  Endothelial Caveolae Have the Molecular Transport Machinery for Vesicle Budding, Docking, and Fusion Including VAMP, NSF, SNAP, Annexins, and GTPases (*) , 1995, The Journal of Biological Chemistry.

[6]  A. Frankel,et al.  Increased cellular uptake of the human immunodeficiency virus-1 Tat protein after modification with biotin. , 1995, Analytical biochemistry.

[7]  A. Prochiantz,et al.  Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro , 1995, The Journal of cell biology.

[8]  B. Lebleu,et al.  Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. , 1994, Nucleic acids research.

[9]  E. Vivés,et al.  Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides , 1994, Journal of virology.

[10]  K Mechtler,et al.  The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. , 1994, The Journal of biological chemistry.

[11]  A. Prochiantz,et al.  The third helix of the Antennapedia homeodomain translocates through biological membranes. , 1994, The Journal of biological chemistry.

[12]  J Barsoum,et al.  Tat-mediated delivery of heterologous proteins into cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Anderson,et al.  Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide. , 1993, Biochemical and biophysical research communications.

[14]  K. Zatloukal,et al.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. G. Anderson,et al.  Potocytosis: sequestration and transport of small molecules by caveolae. , 1992, Science.

[16]  A. Frankel,et al.  Endocytosis and targeting of exogenous HIV‐1 Tat protein. , 1991, The EMBO journal.

[17]  E. Vivés,et al.  Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization. , 1991, Biochemistry.

[18]  T. Haystead,et al.  Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism , 1989, Nature.

[19]  S. Ruben,et al.  Structural and functional characterization of human immunodeficiency virus tat protein , 1989, Journal of virology.

[20]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.